🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Cognizant (CTSH) beat Q2 and lifted its EPS guide, so why did bookings just fall 6%?

Cognizant raised its 2026 EPS guide and deployed $1.1 billion on buybacks, yet Q2 bookings fell 6% and attrition climbed to 13%, complicating the CTSH thesis.

Cognizant Technology Solutions Corporation (Nasdaq: CTSH) reported second-quarter 2026 revenue of $5.481 billion, up 4.5% year-over-year and 4.1% in constant currency, alongside adjusted diluted earnings per share of $1.37 and GAAP diluted earnings per share of $1.36. The Teaneck, New Jersey-headquartered technology services firm raised its full-year 2026 adjusted diluted EPS guidance to a range of $5.70 to $5.82, representing 8% to 10% growth, while trimming the top end of its constant currency revenue growth range to 4.0% to 5.5%. The central tension is straightforward: Financial Services, Cognizant’s largest and most mature segment, delivered a second consecutive quarter of double-digit growth at 12%, but Q2 bookings declined 6% year-over-year, voluntary attrition climbed to 13.0%, and long-term debt tripled to $1.53 billion to fund the completed Astreya acquisition. CTSH shares, which have been trading near 52-week lows after roughly a 47% year-to-date decline entering the print, opened materially higher on the release.

How is Cognizant translating Financial Services momentum into the 2026 growth reset that CTSH holders are pricing?

The single most important operating datapoint in the release is Financial Services revenue of $1.733 billion, up 12.0% year-over-year and 11.7% in constant currency. This is the second consecutive quarter of double-digit growth in the segment, which now contributes 31.6% of group revenue and has overtaken Health Sciences as the largest reporting segment. Chief Executive Officer Ravi Kumar S framed the acceleration as evidence that the company’s AI builder positioning is resonating with enterprise clients, particularly as they shift from AI experimentation toward what Cognizant characterises as enterprise-scale execution.

The other three segments delivered more muted growth. Health Sciences revenue was $1.572 billion, up 1.4% reported and 1.0% in constant currency. Products and Resources was $1.322 billion, up 1.2% reported and 0.7% in constant currency. Communications, Media and Technology was $854 million, up 1.5% reported and 1.4% in constant currency. Cognizant also disclosed that the sale of third-party products in connection with its integrated offerings strategy contributed approximately 170 basis points to consolidated growth in the quarter, including 250 basis points to Financial Services and 350 basis points to Communications, Media and Technology. Stripping that pass-through revenue out, the underlying constant currency growth picture is thinner than the headline number suggests across every segment other than Financial Services. That distinction matters because integrated third-party product resale typically carries a materially lower gross margin than pure services work, which has implications for how the company converts revenue growth into operating leverage.

Why does the $1.1 billion Q2 buyback and the 5.3% share count reduction matter more than the headline revenue beat for CTSH holders?

Cognizant repurchased 22.5 million shares during Q2 for a total outlay of $1.153 billion, comprising 9.7 million shares under a previously announced $500 million accelerated share repurchase programme and a further 12.8 million shares acquired in open market transactions for $653 million. The company has deployed $1.6 billion on buybacks in the first half of 2026, with $2.3 billion remaining under the current authorisation. Diluted share count fell from 492 million in the year-ago quarter to 466 million in Q2 2026, a reduction of approximately 5.3%.

At the pre-release stock level near $47, the $1.153 billion Q2 outlay represents a materially more aggressive capital return posture than the company has run in prior years. Chief Financial Officer Jatin Dalal stated that Cognizant remains focused on funding growth investments and deploying capital strategically, and the first-half breakdown makes the mix explicit: $1.6 billion on buybacks and $1.3 billion on acquisitions in the same six-month window. That combined $2.9 billion of capital deployment is significant against a first-half operating cash flow of $832 million and a first-half free cash flow of $657 million. The gap has been funded through the balance sheet. Cash and cash equivalents fell from $1.901 billion at year-end 2025 to $1.038 billion at 30 June 2026, and long-term debt rose from $543 million to $1.527 billion as the company drew $1.0 billion under its revolving credit facility. The buyback is real, but so is the leverage layered on to sustain it.

See also  Airtel to take stake in Singaporean blockchain technology firm Aqilliz

What does the Astreya acquisition and the Anthropic Global Premier Partner status tell us about Cognizant’s capital priorities under the AI builder strategy?

Cognizant closed its acquisition of Astreya, an AI-first IT managed services and solutions provider, on 22 June 2026 for a purchase price of $634 million including $25 million of contingent consideration, net of cash acquired. Astreya’s stated client base includes six of what Cognizant describes as the Magnificent Seven hyperscalers. The strategic logic is a direct extension of the AI builder positioning: absorb operating capacity that supports complex hyperscaler technology environments and route AI infrastructure managed services work through Cognizant’s own global delivery model.

Alongside the transaction, Cognizant disclosed an expanded partnership with Anthropic under which it becomes one of a small number of Global Premier Partners in the Claude Partner Network. The company said it is embedding Claude across its own business and engineering platforms and scaling a Claude-certified workforce as part of its new Frontier Certified workforce model. It also disclosed a broadened partnership with Google Cloud around Gemini Enterprise deployment, an expanded alliance with Snowflake on the CoCo platform, an OpenAI Daybreak Cyber Partner Program engagement using GPT-5.5 within Cognizant’s Frontier AI Cyber Defense services, and a Rubrik alliance targeting agentic AI resilience. Cognizant simultaneously launched Cognizant Neuro AI Trust as a governance layer and a sovereign Physical AI Platform-as-a-Service offering built on the Cognizant Intelligence Spine.

The strategic direction is coherent. The commercial question that remains open is how quickly this platform and partnership stack converts into contracted, recurring revenue rather than pilot or transformation work with meaningful non-billable investment attached. Recent AI-focused announcements from Cognizant have, according to third-party market feeds, been met with mixed near-term share-price reactions, suggesting investor scepticism about the near-term revenue conversion.

Why should investors watch the Q2 bookings decline even as trailing-twelve-month bookings held at $29.1 billion?

Trailing-twelve-month bookings reached $29.1 billion in Q2, up 5% year-over-year, representing a book-to-bill ratio of approximately 1.3 times. Cognizant signed seven large deals in the quarter, defined as contracts with a total contract value of $100 million or greater. However, Q2 bookings in isolation declined 6% year-over-year, and management did not disclose any mega deals with a total contract value of $500 million or greater in the quarter, in contrast to Q1 2026 when the company signed one such transaction as part of a broader 21% YoY bookings expansion.

See also  Samsung doubles down on local AI with Nota AI—Exynos 2600 gets a turbocharge

The trailing-twelve-month book-to-bill of 1.3 times is healthy in absolute terms, but the compression from the 1.4 times ratio management flagged after Q1 signals a slower pace of new signings in the current quarter. Because bookings are the leading indicator for services revenue that begins to flow four to eight quarters ahead, a 6% year-over-year decline in a single quarter is not by itself a thesis-breaking event. It becomes one only if the pattern extends. Retained visibility on Q3 bookings, and specifically the presence or absence of a mega deal, will be the more useful signal on whether the Q2 miss on new signings reflects timing or a genuine deceleration in enterprise services demand at Cognizant’s price and scale point.

How do rising attrition and a shrinking headcount square with the Frontier Certified workforce build-out?

Voluntary attrition in Technology Services on a trailing-twelve-month basis rose to 13.0% for the period ended 30 June 2026, compared with 12.3% at 31 March 2026 and 12.6% at 30 June 2025. Total headcount at 30 June 2026 stood at 356,700, a decrease of 900 from 31 March 2026 and an increase of 12,900 from 30 June 2025.

The sequential attrition uptick and the sequential headcount decline coincide with the company’s announcement that it plans to scale its Frontier Certified workforce to 5,000 Frontier Certified Engineers and 10,000 Frontier Business Operators, with the first cohort expected in the fourth quarter of 2026. Cognizant also disclosed the launch of its Ace Team Program, described as a selective hiring pathway and centrally governed engineering community aligned to its AI builder strategy. The company is therefore restructuring its talent base in favour of a smaller, more specialised AI-native engineering layer even as attrition among the broader Technology Services base creeps higher. The direction is defensible if labour productivity per Frontier Certified Engineer is materially higher than the average Technology Services headcount, but the near-term consequence is more variable delivery capacity during the transition and the elevated wage costs that come with certified AI talent in a competitive market.

What does the raised 2026 adjusted EPS guide reveal about margin durability and the role of Project Leap at Cognizant?

Full-year 2026 adjusted operating margin guidance was left unchanged at 16.0% to 16.2%, implying 20 to 40 basis points of year-over-year expansion. Full-year adjusted diluted EPS guidance was raised to $5.70 to $5.82, from a prior range implied by first-half performance and consensus expectations, representing 8% to 10% year-over-year growth. Full-year constant currency revenue growth guidance was revised to 4.0% to 5.5%, from prior indications that had implied a slightly wider or higher-end range.

The EPS guidance uplift is being funded partly by the accelerated buyback pace, which mechanically reduces diluted share count, and partly by a one-time benefit. The company recorded an $81 million pre-tax benefit in Q2 selling, general and administrative expenses reflecting a partial reversal of the India Defined Contribution Obligation, following the notification of Social Security Rules by the Government of India in May 2026 and the publication of the Employees Provident Fund Scheme of 2026 in June 2026. Cognizant’s guidance anticipates a pre-tax benefit of approximately $0.18 per diluted share from this reversal at the full-year level. Working in the opposite direction, Project Leap restructuring charges of $84 million were booked in Q2, with the company expecting full-year Project Leap costs of $230 million to $320 million, substantially all of which are expected to be incurred in 2026 and which translate to $0.50 to $0.70 per diluted share of pre-tax charges. The GAAP earnings picture through the balance of 2026 will therefore reflect materially heavier restructuring impact than the adjusted numbers show.

See also  IBM reveals Q3 2023 earnings: Software and consulting sectors shine

What should investors track as Cognizant moves Project Leap costs and the Astreya integration through the second half of 2026?

  • Cognizant reported Q2 2026 revenue of $5.481 billion, up 4.5% year-over-year and 4.1% in constant currency, with adjusted diluted EPS of $1.37 and GAAP diluted EPS of $1.36
  • Financial Services delivered a second consecutive quarter of double-digit growth at 12.0% reported, becoming the largest segment at 31.6% of group revenue
  • Full-year 2026 adjusted diluted EPS guidance was raised to $5.70 to $5.82 for 8% to 10% growth, while constant currency revenue growth guidance was set at 4.0% to 5.5%
  • Cognizant deployed $1.153 billion on Q2 share repurchases, taking first-half buybacks to $1.6 billion, with $2.3 billion remaining under the current authorisation
  • The Astreya acquisition closed on 22 June 2026 for $634 million and was funded partly through a $1.0 billion revolving credit facility drawdown, tripling long-term debt to $1.527 billion
  • Q2 bookings declined 6% year-over-year with no disclosed mega deal, even as trailing-twelve-month bookings rose 5% to $29.1 billion and book-to-bill held at approximately 1.3 times
  • Voluntary attrition in Technology Services rose to 13.0% on a trailing-twelve-month basis, and total headcount fell sequentially by 900 to 356,700
  • Cognizant was named a Global Premier Partner in the Anthropic Claude Partner Network, expanded its Google Cloud Gemini Enterprise partnership, deepened its Snowflake CoCo alliance and joined the OpenAI Daybreak Cyber Partner Program
  • Project Leap restructuring is expected to cost $230 million to $320 million in 2026, partially offset by an $81 million Q2 India Defined Contribution Obligation reversal that flows through selling, general and administrative expenses
  • The next measurable proof point is the Q3 print, where investors will look for Financial Services to sustain double-digit growth, at least one mega deal to return to bookings, and initial revenue contribution from the Frontier Certified workforce cohort due in Q4

Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts